China's 111.inc app starts retail sales of Pfizer's Paxlovid for COVID treatment

China's 111.inc app starts retail sales of Pfizer's Paxlovid for COVID treatment
Representative image Image Credit: Wikimedia Commons
  • Country:
  • China

Chinese healthcare company 111.inc has started selling Pfizer's Paxlovid for COVID treatment in China for 2,980 yuan per box on its app, the sales page on the app showed.

People who test positive for COVID-19 can purchase the oral treatment medication Paxlovid on the app after submitting a positive test result.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.